Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To provide patients with severe hypercholesterolemia at risk for subsequent cardiovascular (CV) events and not adequately controlled with currently available lipid-modifying therapy (LMT) access to alirocumab ahead of commercial availability and to document the overall safety and tolerability of alirocumab in this patient population.
Inclusion criteria
- Hypercholesterolemia